Ipsen announced the appointment of Jonathan Barnsley as executive vice president in charge of technical operations. He will be a member of the Executive Committee of the Ipsen group. He will take up his new position on April 1, reporting directly to Christel Bories, deputy CEO of the Ipsen group.
In line with the new organization implemented in last November, Jonathan Barnsley will be in charge of the Specialty Care production facilities and CMC (Chemistry, Manufacturing and Controls) and will have a functional link to Primary Care production facilities. Support functions to technical operations (purchasing, quality, EHS…) will also report to him.
English and Swiss national, Jonathan Barnsley is graduated from Sheffield University in chemical engineering. He has acquired a broad range of experience in the biotech and pharmaceutical industry on an international level and has held senior positions in manufacturing, development and engineering (notably within Beecham Pharmaceuticals Ltd., GD Searle Company Ltd., Celltech Ltd., Biocompatibles Ltd. and GSK).
He spent the last 18 years within Merck Serono, where he held various positions of leadership in corporate engineering and manufacturing. In 2000, he became site director of Serono Biotech Center (Vevey, CH). In 2007, he was appointed senior vice president of biotech manufacturing with the responsibility of six manufacturing sites and since 2013 senior vice president of biotech development covering the development of processes for transfer to manufacturing.
Date: January 10, 2014
Filed Under: Drug Discovery